Global Pneumococcal Vaccine Market Analysis and Forecast 2024-2030
Summary
Pneumococcal Vaccine is a kind of vaccine used to prevent infection caused by pneumococcal bacteria.
There are two types of Pneumococcal Vaccine: conjugate vaccines and polysaccharide vaccines.
23-Valent Pneumococcal Polysaccharide Vaccine (PPSV 23) is polysaccharide vaccine. Pneumococcal conjugate vaccines contain PCV 7/13 (Pfizer) and PCV10 (GSK).
According to APO Research, The global Pneumococcal Vaccine market is projected to grow from US$ million in 2024 to US$ million by 2030, at a Compound Annual Growth Rate (CAGR) of % during the forecast period.
The US & Canada market for Pneumococcal Vaccine is estimated to increase from $ million in 2024 to reach $ million by 2030, at a CAGR of % during the forecast period of 2025 through 2030.
Asia-Pacific market for Pneumococcal Vaccine is estimated to increase from $ million in 2024 to reach $ million by 2030, at a CAGR of % during the forecast period of 2025 through 2030.
The China market for Pneumococcal Vaccine is estimated to increase from $ million in 2024 to reach $ million by 2030, at a CAGR of % during the forecast period of 2025 through 2030.
Europe market for Pneumococcal Vaccine is estimated to increase from $ million in 2024 to reach $ million by 2030, at a CAGR of % during the forecast period of 2025 through 2030.
The major global manufacturers of Pneumococcal Vaccine include Pfizer, GSK, MSD, Sanofipasteur and CDIBP, etc. In 2023, the world's top three vendors accounted for approximately % of the revenue.
This report presents an overview of global market for Pneumococcal Vaccine, sales, revenue and price. Analyses of the global market trends, with historic market revenue or sales data for 2019 - 2023, estimates for 2024, and projections of CAGR through 2030.
This report researches the key producers of Pneumococcal Vaccine, also provides the sales of main regions and countries. Of the upcoming market potential for Pneumococcal Vaccine, and key regions or countries of focus to forecast this market into various segments and sub-segments. Country specific data and market value analysis for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, Middle East, Africa, and Other Countries.
This report focuses on the Pneumococcal Vaccine sales, revenue, market share and industry ranking of main manufacturers, data from 2019 to 2024. Identification of the major stakeholders in the global Pneumococcal Vaccine market, and analysis of their competitive landscape and market positioning based on recent developments and segmental revenues. This report will help stakeholders to understand the competitive landscape and gain more insights and position their businesses and market strategies in a better way.
This report analyzes the segments data by Type and by Application, sales, revenue, and price, from 2019 to 2030. Evaluation and forecast the market size for Pneumococcal Vaccine sales, projected growth trends, production technology, application and end-user industry.
Pneumococcal Vaccine segment by Company
1. To analyze and research the global status and future forecast, involving growth rate (CAGR), market share, historical and forecast.
2. To present the key manufacturers, sales, revenue, market share, and Recent Developments.
3. To split the breakdown data by regions, type, manufacturers, and Application.
4. To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints, and risks.
5. To identify significant trends, drivers, influence factors in global and regions.
6. To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.
Reasons to Buy This Report
1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Pneumococcal Vaccine market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.
2. This report will help stakeholders to understand the global industry status and trends of Pneumococcal Vaccine and provides them with information on key market drivers, restraints, challenges, and opportunities.
3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in sales and value), competitor ecosystem, new product development, expansion, and acquisition.
4. This report stays updated with novel technology integration, features, and the latest developments in the market.
5. This report helps stakeholders to gain insights into which regions to target globally.
6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Pneumococcal Vaccine.
7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by type and by application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Sales (consumption), revenue of Pneumococcal Vaccine in global, regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space of each country in the world.
Chapter 4: Detailed analysis of Pneumococcal Vaccine manufacturers competitive landscape, price, sales, revenue, market share and industry ranking, latest development plan, merger, and acquisition information, etc.
Chapter 5: Provides the analysis of various market segments by type, covering the sales, revenue, average price, and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 6: Provides the analysis of various market segments by application, covering the sales, revenue, average price, and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 7: Provides profiles of key manufacturers, introducing the basic situation of the main companies in the market in detail, including product descriptions and specifications, Pneumococcal Vaccine sales, revenue, price, gross margin, and recent development, etc.
Chapter 8: North America (US & Canada) by type, by application and by country, sales, and revenue for each segment.
Chapter 9: Europe by type, by application and by country, sales, and revenue for each segment.
Chapter 10: China type, by application, sales, and revenue for each segment.
Chapter 11: Asia (excluding China) type, by application and by region, sales, and revenue for each segment.
Chapter 12: Middle East, Africa, and Latin America type, by application and by country, sales, and revenue for each segment.
Chapter 13: Analysis of industrial chain, sales channel, key raw materials, distributors and customers.
Chapter 14: The main concluding insights of the report.
Pneumococcal Vaccine is a kind of vaccine used to prevent infection caused by pneumococcal bacteria.
There are two types of Pneumococcal Vaccine: conjugate vaccines and polysaccharide vaccines.
23-Valent Pneumococcal Polysaccharide Vaccine (PPSV 23) is polysaccharide vaccine. Pneumococcal conjugate vaccines contain PCV 7/13 (Pfizer) and PCV10 (GSK).
According to APO Research, The global Pneumococcal Vaccine market is projected to grow from US$ million in 2024 to US$ million by 2030, at a Compound Annual Growth Rate (CAGR) of % during the forecast period.
The US & Canada market for Pneumococcal Vaccine is estimated to increase from $ million in 2024 to reach $ million by 2030, at a CAGR of % during the forecast period of 2025 through 2030.
Asia-Pacific market for Pneumococcal Vaccine is estimated to increase from $ million in 2024 to reach $ million by 2030, at a CAGR of % during the forecast period of 2025 through 2030.
The China market for Pneumococcal Vaccine is estimated to increase from $ million in 2024 to reach $ million by 2030, at a CAGR of % during the forecast period of 2025 through 2030.
Europe market for Pneumococcal Vaccine is estimated to increase from $ million in 2024 to reach $ million by 2030, at a CAGR of % during the forecast period of 2025 through 2030.
The major global manufacturers of Pneumococcal Vaccine include Pfizer, GSK, MSD, Sanofipasteur and CDIBP, etc. In 2023, the world's top three vendors accounted for approximately % of the revenue.
This report presents an overview of global market for Pneumococcal Vaccine, sales, revenue and price. Analyses of the global market trends, with historic market revenue or sales data for 2019 - 2023, estimates for 2024, and projections of CAGR through 2030.
This report researches the key producers of Pneumococcal Vaccine, also provides the sales of main regions and countries. Of the upcoming market potential for Pneumococcal Vaccine, and key regions or countries of focus to forecast this market into various segments and sub-segments. Country specific data and market value analysis for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, Middle East, Africa, and Other Countries.
This report focuses on the Pneumococcal Vaccine sales, revenue, market share and industry ranking of main manufacturers, data from 2019 to 2024. Identification of the major stakeholders in the global Pneumococcal Vaccine market, and analysis of their competitive landscape and market positioning based on recent developments and segmental revenues. This report will help stakeholders to understand the competitive landscape and gain more insights and position their businesses and market strategies in a better way.
This report analyzes the segments data by Type and by Application, sales, revenue, and price, from 2019 to 2030. Evaluation and forecast the market size for Pneumococcal Vaccine sales, projected growth trends, production technology, application and end-user industry.
Pneumococcal Vaccine segment by Company
- Pfizer
- GSK
- MSD
- Sanofipasteur
- CDIBP
- PPSV 23
- PCV 7/13
- PCV 10
- Child
- Adult
- North America
- U.S.
- Canada
- Europe
- Germany
- France
- U.K.
- Italy
- Russia
- Asia-Pacific
- China
- Japan
- South Korea
- India
- Australia
- China Taiwan
- Indonesia
- Thailand
- Malaysia
- Latin America
- Mexico
- Brazil
- Argentina
- Middle East & Africa
- Turkey
- Saudi Arabia
- UAE
1. To analyze and research the global status and future forecast, involving growth rate (CAGR), market share, historical and forecast.
2. To present the key manufacturers, sales, revenue, market share, and Recent Developments.
3. To split the breakdown data by regions, type, manufacturers, and Application.
4. To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints, and risks.
5. To identify significant trends, drivers, influence factors in global and regions.
6. To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.
Reasons to Buy This Report
1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Pneumococcal Vaccine market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.
2. This report will help stakeholders to understand the global industry status and trends of Pneumococcal Vaccine and provides them with information on key market drivers, restraints, challenges, and opportunities.
3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in sales and value), competitor ecosystem, new product development, expansion, and acquisition.
4. This report stays updated with novel technology integration, features, and the latest developments in the market.
5. This report helps stakeholders to gain insights into which regions to target globally.
6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Pneumococcal Vaccine.
7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by type and by application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Sales (consumption), revenue of Pneumococcal Vaccine in global, regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space of each country in the world.
Chapter 4: Detailed analysis of Pneumococcal Vaccine manufacturers competitive landscape, price, sales, revenue, market share and industry ranking, latest development plan, merger, and acquisition information, etc.
Chapter 5: Provides the analysis of various market segments by type, covering the sales, revenue, average price, and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 6: Provides the analysis of various market segments by application, covering the sales, revenue, average price, and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 7: Provides profiles of key manufacturers, introducing the basic situation of the main companies in the market in detail, including product descriptions and specifications, Pneumococcal Vaccine sales, revenue, price, gross margin, and recent development, etc.
Chapter 8: North America (US & Canada) by type, by application and by country, sales, and revenue for each segment.
Chapter 9: Europe by type, by application and by country, sales, and revenue for each segment.
Chapter 10: China type, by application, sales, and revenue for each segment.
Chapter 11: Asia (excluding China) type, by application and by region, sales, and revenue for each segment.
Chapter 12: Middle East, Africa, and Latin America type, by application and by country, sales, and revenue for each segment.
Chapter 13: Analysis of industrial chain, sales channel, key raw materials, distributors and customers.
Chapter 14: The main concluding insights of the report.
1 MARKET OVERVIEW
1.1 Product Definition
1.2 Pneumococcal Vaccine Market by Type
1.2.1 Global Pneumococcal Vaccine Market Size by Type, 2019 VS 2023 VS 2030
1.2.2 PPSV
1.2.3 PCV 7/13
1.2.4 PCV
1.3 Pneumococcal Vaccine Market by End User
1.3.1 Global Pneumococcal Vaccine Market Size by End User, 2019 VS 2023 VS 2030
1.3.2 Child
1.3.3 Adult
1.4 Assumptions and Limitations
1.5 Study Goals and Objectives
2 PNEUMOCOCCAL VACCINE MARKET DYNAMICS
2.1 Pneumococcal Vaccine Industry Trends
2.2 Pneumococcal Vaccine Industry Drivers
2.3 Pneumococcal Vaccine Industry Opportunities and Challenges
2.4 Pneumococcal Vaccine Industry Restraints
3 GLOBAL MARKET GROWTH PROSPECTS
3.1 Global Pneumococcal Vaccine Revenue Estimates and Forecasts (2019-2030)
3.2 Global Pneumococcal Vaccine Revenue by Region
3.2.1 Global Pneumococcal Vaccine Revenue by Region: 2019 VS 2023 VS 2030
3.2.2 Global Pneumococcal Vaccine Revenue by Region (2019-2024)
3.2.3 Global Pneumococcal Vaccine Revenue by Region (2025-2030)
3.2.4 Global Pneumococcal Vaccine Revenue Market Share by Region (2019-2030)
3.3 Global Pneumococcal Vaccine Sales Estimates and Forecasts 2019-2030
3.4 Global Pneumococcal Vaccine Sales by Region
3.4.1 Global Pneumococcal Vaccine Sales by Region: 2019 VS 2023 VS 2030
3.4.2 Global Pneumococcal Vaccine Sales by Region (2019-2024)
3.4.3 Global Pneumococcal Vaccine Sales by Region (2025-2030)
3.4.4 Global Pneumococcal Vaccine Sales Market Share by Region (2019-2030)
3.5 US & Canada
3.6 Europe
3.7 China
3.8 Asia (Excluding China)
3.9 Middle East, Africa and Latin America
4 MARKET COMPETITIVE LANDSCAPE BY MANUFACTURERS
4.1 Global Pneumococcal Vaccine Revenue by Manufacturers
4.1.1 Global Pneumococcal Vaccine Revenue by Manufacturers (2019-2024)
4.1.2 Global Pneumococcal Vaccine Revenue Market Share by Manufacturers (2019-2024)
4.1.3 Global Pneumococcal Vaccine Manufacturers Revenue Share Top 10 and Top 5 in 2023
4.2 Global Pneumococcal Vaccine Sales by Manufacturers
4.2.1 Global Pneumococcal Vaccine Sales by Manufacturers (2019-2024)
4.2.2 Global Pneumococcal Vaccine Sales Market Share by Manufacturers (2019-2024)
4.2.3 Global Pneumococcal Vaccine Manufacturers Sales Share Top 10 and Top 5 in 2023
4.3 Global Pneumococcal Vaccine Sales Price by Manufacturers (2019-2024)
4.4 Global Pneumococcal Vaccine Key Manufacturers Ranking, 2022 VS 2023 VS 2024
4.5 Global Pneumococcal Vaccine Key Manufacturers Manufacturing Sites & Headquarters
4.6 Global Pneumococcal Vaccine Manufacturers, Product Type & Application
4.7 Global Pneumococcal Vaccine Manufacturers Commercialization Time
4.8 Market Competitive Analysis
4.8.1 Global Pneumococcal Vaccine Market CR5 and HHI
4.8.2 2023 Pneumococcal Vaccine Tier 1, Tier 2, and Tier
5 PNEUMOCOCCAL VACCINE MARKET BY TYPE
5.1 Global Pneumococcal Vaccine Revenue by Type
5.1.1 Global Pneumococcal Vaccine Revenue by Type (2019 VS 2023 VS 2030)
5.1.2 Global Pneumococcal Vaccine Revenue by Type (2019-2030) & (US$ Million)
5.1.3 Global Pneumococcal Vaccine Revenue Market Share by Type (2019-2030)
5.2 Global Pneumococcal Vaccine Sales by Type
5.2.1 Global Pneumococcal Vaccine Sales by Type (2019 VS 2023 VS 2030)
5.2.2 Global Pneumococcal Vaccine Sales by Type (2019-2030) & (K Doses)
5.2.3 Global Pneumococcal Vaccine Sales Market Share by Type (2019-2030)
5.3 Global Pneumococcal Vaccine Price by Type
6 PNEUMOCOCCAL VACCINE MARKET BY APPLICATION
6.1 Global Pneumococcal Vaccine Revenue by Application
6.1.1 Global Pneumococcal Vaccine Revenue by Application (2019 VS 2023 VS 2030)
6.1.2 Global Pneumococcal Vaccine Revenue by Application (2019-2030) & (US$ Million)
6.1.3 Global Pneumococcal Vaccine Revenue Market Share by Application (2019-2030)
6.2 Global Pneumococcal Vaccine Sales by Application
6.2.1 Global Pneumococcal Vaccine Sales by Application (2019 VS 2023 VS 2030)
6.2.2 Global Pneumococcal Vaccine Sales by Application (2019-2030) & (K Doses)
6.2.3 Global Pneumococcal Vaccine Sales Market Share by Application (2019-2030)
6.3 Global Pneumococcal Vaccine Price by Application
7 COMPANY PROFILES
7.1 Pfizer
7.1.1 Pfizer Comapny Information
7.1.2 Pfizer Business Overview
7.1.3 Pfizer Pneumococcal Vaccine Sales, Revenue, Price and Gross Margin (2019-2024)
7.1.4 Pfizer Pneumococcal Vaccine Product Portfolio
7.1.5 Pfizer Recent Developments
7.2 GSK
7.2.1 GSK Comapny Information
7.2.2 GSK Business Overview
7.2.3 GSK Pneumococcal Vaccine Sales, Revenue, Price and Gross Margin (2019-2024)
7.2.4 GSK Pneumococcal Vaccine Product Portfolio
7.2.5 GSK Recent Developments
7.3 MSD
7.3.1 MSD Comapny Information
7.3.2 MSD Business Overview
7.3.3 MSD Pneumococcal Vaccine Sales, Revenue, Price and Gross Margin (2019-2024)
7.3.4 MSD Pneumococcal Vaccine Product Portfolio
7.3.5 MSD Recent Developments
7.4 Sanofipasteur
7.4.1 Sanofipasteur Comapny Information
7.4.2 Sanofipasteur Business Overview
7.4.3 Sanofipasteur Pneumococcal Vaccine Sales, Revenue, Price and Gross Margin (2019-2024)
7.4.4 Sanofipasteur Pneumococcal Vaccine Product Portfolio
7.4.5 Sanofipasteur Recent Developments
7.5 CDIBP
7.5.1 CDIBP Comapny Information
7.5.2 CDIBP Business Overview
7.5.3 CDIBP Pneumococcal Vaccine Sales, Revenue, Price and Gross Margin (2019-2024)
7.5.4 CDIBP Pneumococcal Vaccine Product Portfolio
7.5.5 CDIBP Recent Developments
8 NORTH AMERICA
8.1 North America Pneumococcal Vaccine Market Size by Type
8.1.1 North America Pneumococcal Vaccine Revenue by Type (2019-2030)
8.1.2 North America Pneumococcal Vaccine Sales by Type (2019-2030)
8.1.3 North America Pneumococcal Vaccine Price by Type (2019-2030)
8.2 North America Pneumococcal Vaccine Market Size by End User
8.2.1 North America Pneumococcal Vaccine Revenue by End User (2019-2030)
8.2.2 North America Pneumococcal Vaccine Sales by End User (2019-2030)
8.2.3 North America Pneumococcal Vaccine Price by End User (2019-2030)
8.3 North America Pneumococcal Vaccine Market Size by Country
8.3.1 North America Pneumococcal Vaccine Revenue Grow Rate by Country (2019 VS 2023 VS 2030)
8.3.2 North America Pneumococcal Vaccine Sales by Country (2019 VS 2023 VS 2030)
8.3.3 North America Pneumococcal Vaccine Price by Country (2019-2030)
8.3.4 U.S.
8.3.5 Canada
9 EUROPE
9.1 Europe Pneumococcal Vaccine Market Size by Type
9.1.1 Europe Pneumococcal Vaccine Revenue by Type (2019-2030)
9.1.2 Europe Pneumococcal Vaccine Sales by Type (2019-2030)
9.1.3 Europe Pneumococcal Vaccine Price by Type (2019-2030)
9.2 Europe Pneumococcal Vaccine Market Size by End User
9.2.1 Europe Pneumococcal Vaccine Revenue by End User (2019-2030)
9.2.2 Europe Pneumococcal Vaccine Sales by End User (2019-2030)
9.2.3 Europe Pneumococcal Vaccine Price by End User (2019-2030)
9.3 Europe Pneumococcal Vaccine Market Size by Country
9.3.1 Europe Pneumococcal Vaccine Revenue Grow Rate by Country (2019 VS 2023 VS 2030)
9.3.2 Europe Pneumococcal Vaccine Sales by Country (2019 VS 2023 VS 2030)
9.3.3 Europe Pneumococcal Vaccine Price by Country (2019-2030)
9.3.4 Germany
9.3.5 France
9.3.6 U.K.
9.3.7 Italy
9.3.8 Russia
10 CHINA
10.1 China Pneumococcal Vaccine Market Size by Type
10.1.1 China Pneumococcal Vaccine Revenue by Type (2019-2030)
10.1.2 China Pneumococcal Vaccine Sales by Type (2019-2030)
10.1.3 China Pneumococcal Vaccine Price by Type (2019-2030)
10.2 China Pneumococcal Vaccine Market Size by End User
10.2.1 China Pneumococcal Vaccine Revenue by End User (2019-2030)
10.2.2 China Pneumococcal Vaccine Sales by End User (2019-2030)
10.2.3 China Pneumococcal Vaccine Price by End User (2019-2030)
11 ASIA (EXCLUDING CHINA)
11.1 Asia Pneumococcal Vaccine Market Size by Type
11.1.1 Asia Pneumococcal Vaccine Revenue by Type (2019-2030)
11.1.2 Asia Pneumococcal Vaccine Sales by Type (2019-2030)
11.1.3 Asia Pneumococcal Vaccine Price by Type (2019-2030)
11.2 Asia Pneumococcal Vaccine Market Size by End User
11.2.1 Asia Pneumococcal Vaccine Revenue by End User (2019-2030)
11.2.2 Asia Pneumococcal Vaccine Sales by End User (2019-2030)
11.2.3 Asia Pneumococcal Vaccine Price by End User (2019-2030)
11.3 Asia Pneumococcal Vaccine Market Size by Country
11.3.1 Asia Pneumococcal Vaccine Revenue Grow Rate by Country (2019 VS 2023 VS 2030)
11.3.2 Asia Pneumococcal Vaccine Sales by Country (2019 VS 2023 VS 2030)
11.3.3 Asia Pneumococcal Vaccine Price by Country (2019-2030)
11.3.4 Japan
11.3.5 South Korea
11.3.6 India
11.3.7 Australia
11.3.8 China Taiwan
11.3.9 Southeast Asia
12 MIDDLE EAST, AFRICA AND LATIN AMERICA
12.1 MEALA Pneumococcal Vaccine Market Size by Type
12.1.1 MEALA Pneumococcal Vaccine Revenue by Type (2019-2030)
12.1.2 MEALA Pneumococcal Vaccine Sales by Type (2019-2030)
12.1.3 MEALA Pneumococcal Vaccine Price by Type (2019-2030)
12.2 MEALA Pneumococcal Vaccine Market Size by End User
12.2.1 MEALA Pneumococcal Vaccine Revenue by End User (2019-2030)
12.2.2 MEALA Pneumococcal Vaccine Sales by End User (2019-2030)
12.2.3 MEALA Pneumococcal Vaccine Price by End User (2019-2030)
12.3 MEALA Pneumococcal Vaccine Market Size by Country
12.3.1 MEALA Pneumococcal Vaccine Revenue Grow Rate by Country (2019 VS 2023 VS 2030)
12.3.2 MEALA Pneumococcal Vaccine Sales by Country (2019 VS 2023 VS 2030)
12.3.3 MEALA Pneumococcal Vaccine Price by Country (2019-2030)
12.3.4 Mexico
12.3.5 Brazil
12.3.6 Israel
12.3.7 Argentina
12.3.8 Colombia
12.3.9 Turkey
12.3.10 Saudi Arabia
12.3.11 UAE
13 VALUE CHAIN AND SALES CHANNELS ANALYSIS
13.1 Pneumococcal Vaccine Value Chain Analysis
13.1.1 Pneumococcal Vaccine Key Raw Materials
13.1.2 Raw Materials Key Suppliers
13.1.3 Manufacturing Cost Structure
13.1.4 Pneumococcal Vaccine Production Mode & Process
13.2 Pneumococcal Vaccine Sales Channels Analysis
13.2.1 Direct Comparison with Distribution Share
13.2.2 Pneumococcal Vaccine Distributors
13.2.3 Pneumococcal Vaccine Customers
14 CONCLUDING INSIGHTS
15 APPENDIX
15.1 Reasons for Doing This Study
15.2 Research Methodology
15.3 Research Process
15.4 Authors List of This Report
15.5 Data Source
15.5.1 Secondary Sources
15.5.2 Primary Sources
15.6 Disclaimer
1.1 Product Definition
1.2 Pneumococcal Vaccine Market by Type
1.2.1 Global Pneumococcal Vaccine Market Size by Type, 2019 VS 2023 VS 2030
1.2.2 PPSV
1.2.3 PCV 7/13
1.2.4 PCV
1.3 Pneumococcal Vaccine Market by End User
1.3.1 Global Pneumococcal Vaccine Market Size by End User, 2019 VS 2023 VS 2030
1.3.2 Child
1.3.3 Adult
1.4 Assumptions and Limitations
1.5 Study Goals and Objectives
2 PNEUMOCOCCAL VACCINE MARKET DYNAMICS
2.1 Pneumococcal Vaccine Industry Trends
2.2 Pneumococcal Vaccine Industry Drivers
2.3 Pneumococcal Vaccine Industry Opportunities and Challenges
2.4 Pneumococcal Vaccine Industry Restraints
3 GLOBAL MARKET GROWTH PROSPECTS
3.1 Global Pneumococcal Vaccine Revenue Estimates and Forecasts (2019-2030)
3.2 Global Pneumococcal Vaccine Revenue by Region
3.2.1 Global Pneumococcal Vaccine Revenue by Region: 2019 VS 2023 VS 2030
3.2.2 Global Pneumococcal Vaccine Revenue by Region (2019-2024)
3.2.3 Global Pneumococcal Vaccine Revenue by Region (2025-2030)
3.2.4 Global Pneumococcal Vaccine Revenue Market Share by Region (2019-2030)
3.3 Global Pneumococcal Vaccine Sales Estimates and Forecasts 2019-2030
3.4 Global Pneumococcal Vaccine Sales by Region
3.4.1 Global Pneumococcal Vaccine Sales by Region: 2019 VS 2023 VS 2030
3.4.2 Global Pneumococcal Vaccine Sales by Region (2019-2024)
3.4.3 Global Pneumococcal Vaccine Sales by Region (2025-2030)
3.4.4 Global Pneumococcal Vaccine Sales Market Share by Region (2019-2030)
3.5 US & Canada
3.6 Europe
3.7 China
3.8 Asia (Excluding China)
3.9 Middle East, Africa and Latin America
4 MARKET COMPETITIVE LANDSCAPE BY MANUFACTURERS
4.1 Global Pneumococcal Vaccine Revenue by Manufacturers
4.1.1 Global Pneumococcal Vaccine Revenue by Manufacturers (2019-2024)
4.1.2 Global Pneumococcal Vaccine Revenue Market Share by Manufacturers (2019-2024)
4.1.3 Global Pneumococcal Vaccine Manufacturers Revenue Share Top 10 and Top 5 in 2023
4.2 Global Pneumococcal Vaccine Sales by Manufacturers
4.2.1 Global Pneumococcal Vaccine Sales by Manufacturers (2019-2024)
4.2.2 Global Pneumococcal Vaccine Sales Market Share by Manufacturers (2019-2024)
4.2.3 Global Pneumococcal Vaccine Manufacturers Sales Share Top 10 and Top 5 in 2023
4.3 Global Pneumococcal Vaccine Sales Price by Manufacturers (2019-2024)
4.4 Global Pneumococcal Vaccine Key Manufacturers Ranking, 2022 VS 2023 VS 2024
4.5 Global Pneumococcal Vaccine Key Manufacturers Manufacturing Sites & Headquarters
4.6 Global Pneumococcal Vaccine Manufacturers, Product Type & Application
4.7 Global Pneumococcal Vaccine Manufacturers Commercialization Time
4.8 Market Competitive Analysis
4.8.1 Global Pneumococcal Vaccine Market CR5 and HHI
4.8.2 2023 Pneumococcal Vaccine Tier 1, Tier 2, and Tier
5 PNEUMOCOCCAL VACCINE MARKET BY TYPE
5.1 Global Pneumococcal Vaccine Revenue by Type
5.1.1 Global Pneumococcal Vaccine Revenue by Type (2019 VS 2023 VS 2030)
5.1.2 Global Pneumococcal Vaccine Revenue by Type (2019-2030) & (US$ Million)
5.1.3 Global Pneumococcal Vaccine Revenue Market Share by Type (2019-2030)
5.2 Global Pneumococcal Vaccine Sales by Type
5.2.1 Global Pneumococcal Vaccine Sales by Type (2019 VS 2023 VS 2030)
5.2.2 Global Pneumococcal Vaccine Sales by Type (2019-2030) & (K Doses)
5.2.3 Global Pneumococcal Vaccine Sales Market Share by Type (2019-2030)
5.3 Global Pneumococcal Vaccine Price by Type
6 PNEUMOCOCCAL VACCINE MARKET BY APPLICATION
6.1 Global Pneumococcal Vaccine Revenue by Application
6.1.1 Global Pneumococcal Vaccine Revenue by Application (2019 VS 2023 VS 2030)
6.1.2 Global Pneumococcal Vaccine Revenue by Application (2019-2030) & (US$ Million)
6.1.3 Global Pneumococcal Vaccine Revenue Market Share by Application (2019-2030)
6.2 Global Pneumococcal Vaccine Sales by Application
6.2.1 Global Pneumococcal Vaccine Sales by Application (2019 VS 2023 VS 2030)
6.2.2 Global Pneumococcal Vaccine Sales by Application (2019-2030) & (K Doses)
6.2.3 Global Pneumococcal Vaccine Sales Market Share by Application (2019-2030)
6.3 Global Pneumococcal Vaccine Price by Application
7 COMPANY PROFILES
7.1 Pfizer
7.1.1 Pfizer Comapny Information
7.1.2 Pfizer Business Overview
7.1.3 Pfizer Pneumococcal Vaccine Sales, Revenue, Price and Gross Margin (2019-2024)
7.1.4 Pfizer Pneumococcal Vaccine Product Portfolio
7.1.5 Pfizer Recent Developments
7.2 GSK
7.2.1 GSK Comapny Information
7.2.2 GSK Business Overview
7.2.3 GSK Pneumococcal Vaccine Sales, Revenue, Price and Gross Margin (2019-2024)
7.2.4 GSK Pneumococcal Vaccine Product Portfolio
7.2.5 GSK Recent Developments
7.3 MSD
7.3.1 MSD Comapny Information
7.3.2 MSD Business Overview
7.3.3 MSD Pneumococcal Vaccine Sales, Revenue, Price and Gross Margin (2019-2024)
7.3.4 MSD Pneumococcal Vaccine Product Portfolio
7.3.5 MSD Recent Developments
7.4 Sanofipasteur
7.4.1 Sanofipasteur Comapny Information
7.4.2 Sanofipasteur Business Overview
7.4.3 Sanofipasteur Pneumococcal Vaccine Sales, Revenue, Price and Gross Margin (2019-2024)
7.4.4 Sanofipasteur Pneumococcal Vaccine Product Portfolio
7.4.5 Sanofipasteur Recent Developments
7.5 CDIBP
7.5.1 CDIBP Comapny Information
7.5.2 CDIBP Business Overview
7.5.3 CDIBP Pneumococcal Vaccine Sales, Revenue, Price and Gross Margin (2019-2024)
7.5.4 CDIBP Pneumococcal Vaccine Product Portfolio
7.5.5 CDIBP Recent Developments
8 NORTH AMERICA
8.1 North America Pneumococcal Vaccine Market Size by Type
8.1.1 North America Pneumococcal Vaccine Revenue by Type (2019-2030)
8.1.2 North America Pneumococcal Vaccine Sales by Type (2019-2030)
8.1.3 North America Pneumococcal Vaccine Price by Type (2019-2030)
8.2 North America Pneumococcal Vaccine Market Size by End User
8.2.1 North America Pneumococcal Vaccine Revenue by End User (2019-2030)
8.2.2 North America Pneumococcal Vaccine Sales by End User (2019-2030)
8.2.3 North America Pneumococcal Vaccine Price by End User (2019-2030)
8.3 North America Pneumococcal Vaccine Market Size by Country
8.3.1 North America Pneumococcal Vaccine Revenue Grow Rate by Country (2019 VS 2023 VS 2030)
8.3.2 North America Pneumococcal Vaccine Sales by Country (2019 VS 2023 VS 2030)
8.3.3 North America Pneumococcal Vaccine Price by Country (2019-2030)
8.3.4 U.S.
8.3.5 Canada
9 EUROPE
9.1 Europe Pneumococcal Vaccine Market Size by Type
9.1.1 Europe Pneumococcal Vaccine Revenue by Type (2019-2030)
9.1.2 Europe Pneumococcal Vaccine Sales by Type (2019-2030)
9.1.3 Europe Pneumococcal Vaccine Price by Type (2019-2030)
9.2 Europe Pneumococcal Vaccine Market Size by End User
9.2.1 Europe Pneumococcal Vaccine Revenue by End User (2019-2030)
9.2.2 Europe Pneumococcal Vaccine Sales by End User (2019-2030)
9.2.3 Europe Pneumococcal Vaccine Price by End User (2019-2030)
9.3 Europe Pneumococcal Vaccine Market Size by Country
9.3.1 Europe Pneumococcal Vaccine Revenue Grow Rate by Country (2019 VS 2023 VS 2030)
9.3.2 Europe Pneumococcal Vaccine Sales by Country (2019 VS 2023 VS 2030)
9.3.3 Europe Pneumococcal Vaccine Price by Country (2019-2030)
9.3.4 Germany
9.3.5 France
9.3.6 U.K.
9.3.7 Italy
9.3.8 Russia
10 CHINA
10.1 China Pneumococcal Vaccine Market Size by Type
10.1.1 China Pneumococcal Vaccine Revenue by Type (2019-2030)
10.1.2 China Pneumococcal Vaccine Sales by Type (2019-2030)
10.1.3 China Pneumococcal Vaccine Price by Type (2019-2030)
10.2 China Pneumococcal Vaccine Market Size by End User
10.2.1 China Pneumococcal Vaccine Revenue by End User (2019-2030)
10.2.2 China Pneumococcal Vaccine Sales by End User (2019-2030)
10.2.3 China Pneumococcal Vaccine Price by End User (2019-2030)
11 ASIA (EXCLUDING CHINA)
11.1 Asia Pneumococcal Vaccine Market Size by Type
11.1.1 Asia Pneumococcal Vaccine Revenue by Type (2019-2030)
11.1.2 Asia Pneumococcal Vaccine Sales by Type (2019-2030)
11.1.3 Asia Pneumococcal Vaccine Price by Type (2019-2030)
11.2 Asia Pneumococcal Vaccine Market Size by End User
11.2.1 Asia Pneumococcal Vaccine Revenue by End User (2019-2030)
11.2.2 Asia Pneumococcal Vaccine Sales by End User (2019-2030)
11.2.3 Asia Pneumococcal Vaccine Price by End User (2019-2030)
11.3 Asia Pneumococcal Vaccine Market Size by Country
11.3.1 Asia Pneumococcal Vaccine Revenue Grow Rate by Country (2019 VS 2023 VS 2030)
11.3.2 Asia Pneumococcal Vaccine Sales by Country (2019 VS 2023 VS 2030)
11.3.3 Asia Pneumococcal Vaccine Price by Country (2019-2030)
11.3.4 Japan
11.3.5 South Korea
11.3.6 India
11.3.7 Australia
11.3.8 China Taiwan
11.3.9 Southeast Asia
12 MIDDLE EAST, AFRICA AND LATIN AMERICA
12.1 MEALA Pneumococcal Vaccine Market Size by Type
12.1.1 MEALA Pneumococcal Vaccine Revenue by Type (2019-2030)
12.1.2 MEALA Pneumococcal Vaccine Sales by Type (2019-2030)
12.1.3 MEALA Pneumococcal Vaccine Price by Type (2019-2030)
12.2 MEALA Pneumococcal Vaccine Market Size by End User
12.2.1 MEALA Pneumococcal Vaccine Revenue by End User (2019-2030)
12.2.2 MEALA Pneumococcal Vaccine Sales by End User (2019-2030)
12.2.3 MEALA Pneumococcal Vaccine Price by End User (2019-2030)
12.3 MEALA Pneumococcal Vaccine Market Size by Country
12.3.1 MEALA Pneumococcal Vaccine Revenue Grow Rate by Country (2019 VS 2023 VS 2030)
12.3.2 MEALA Pneumococcal Vaccine Sales by Country (2019 VS 2023 VS 2030)
12.3.3 MEALA Pneumococcal Vaccine Price by Country (2019-2030)
12.3.4 Mexico
12.3.5 Brazil
12.3.6 Israel
12.3.7 Argentina
12.3.8 Colombia
12.3.9 Turkey
12.3.10 Saudi Arabia
12.3.11 UAE
13 VALUE CHAIN AND SALES CHANNELS ANALYSIS
13.1 Pneumococcal Vaccine Value Chain Analysis
13.1.1 Pneumococcal Vaccine Key Raw Materials
13.1.2 Raw Materials Key Suppliers
13.1.3 Manufacturing Cost Structure
13.1.4 Pneumococcal Vaccine Production Mode & Process
13.2 Pneumococcal Vaccine Sales Channels Analysis
13.2.1 Direct Comparison with Distribution Share
13.2.2 Pneumococcal Vaccine Distributors
13.2.3 Pneumococcal Vaccine Customers
14 CONCLUDING INSIGHTS
15 APPENDIX
15.1 Reasons for Doing This Study
15.2 Research Methodology
15.3 Research Process
15.4 Authors List of This Report
15.5 Data Source
15.5.1 Secondary Sources
15.5.2 Primary Sources
15.6 Disclaimer
LIST OF TABLES
Table 1. Global Pneumococcal Vaccine Market Size Growth Rate by Type (US$ Million), 2019 VS 2023 VS 2030
Table 2. PPSV 23 Major Manufacturers
Table 3. PCV 7/13 Major Manufacturers
Table 4. PCV 10 Major Manufacturers
Table 5. Global Pneumococcal Vaccine Market Size Growth Rate by End User (US$ Million), 2019 VS 2023 VS 2030
Table 6. Child Major Manufacturers
Table 7. Adult Major Manufacturers
Table 8. Pneumococcal Vaccine Industry Trends
Table 9. Pneumococcal Vaccine Industry Drivers
Table 10. Pneumococcal Vaccine Industry Opportunities and Challenges
Table 11. Pneumococcal Vaccine Industry Restraints
Table 12. Global Pneumococcal Vaccine Revenue Grow Rate (CAGR) by Region: 2019 VS 2023 VS 2030 (US$ Million)
Table 13. Global Pneumococcal Vaccine Revenue by Region (2019-2024) & (US$ Million)
Table 14. Global Pneumococcal Vaccine Revenue by Region (2025-2030) & (US$ Million)
Table 15. Global Pneumococcal Vaccine Revenue Market Share by Region (2019-2024)
Table 16. Global Pneumococcal Vaccine Revenue Market Share by Region (2025-2030)
Table 17. Global Pneumococcal Vaccine Sales Grow Rate (CAGR) by Region: 2019 VS 2023 VS 2030 (K Doses)
Table 18. Global Pneumococcal Vaccine Sales by Region (2019-2024) & (K Doses)
Table 19. Global Pneumococcal Vaccine Sales by Region (2025-2030) & (K Doses)
Table 20. Global Pneumococcal Vaccine Sales Market Share by Region (2019-2024)
Table 21. Global Pneumococcal Vaccine Sales Market Share by Region (2025-2030)
Table 22. Global Pneumococcal Vaccine Revenue by Manufacturers (US$ Million) & (2019-2024)
Table 23. Global Pneumococcal Vaccine Revenue Market Share by Manufacturers (2019-2024)
Table 24. Global Pneumococcal Vaccine Sales by Manufacturers (US$ Million) & (2019-2024)
Table 25. Global Pneumococcal Vaccine Sales Market Share by Manufacturers (2019-2024)
Table 26. Global Pneumococcal Vaccine Sales Price (USD/Dose) of Manufacturers (2019-2024)
Table 27. Global Pneumococcal Vaccine Key Manufacturers Ranking, 2022 VS 2023 VS 2024
Table 28. Global Pneumococcal Vaccine Key Manufacturers Manufacturing Sites & Headquarters
Table 29. Global Pneumococcal Vaccine Manufacturers, Product Type & Application
Table 30. Global Pneumococcal Vaccine Manufacturers Commercialization Time
Table 31. Global Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 32. Global Pneumococcal Vaccine by Manufacturers Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue of 2023)
Table 33. Global Pneumococcal Vaccine Revenue by Type 2019 VS 2023 VS 2030 (US$ Million)
Table 34. Global Pneumococcal Vaccine Revenue by Type (2019-2024) & (US$ Million)
Table 35. Global Pneumococcal Vaccine Revenue by Type (2025-2030) & (US$ Million)
Table 36. Global Pneumococcal Vaccine Revenue Market Share by Type (2019-2024)
Table 37. Global Pneumococcal Vaccine Revenue Market Share by Type (2025-2030)
Table 38. Global Pneumococcal Vaccine Sales by Type 2019 VS 2023 VS 2030 (K Doses)
Table 39. Global Pneumococcal Vaccine Sales by Type (2019-2024) & (K Doses)
Table 40. Global Pneumococcal Vaccine Sales by Type (2025-2030) & (K Doses)
Table 41. Global Pneumococcal Vaccine Sales Market Share by Type (2019-2024)
Table 42. Global Pneumococcal Vaccine Sales Market Share by Type (2025-2030)
Table 43. Global Pneumococcal Vaccine Price by Type (2019-2024) & (USD/Dose)
Table 44. Global Pneumococcal Vaccine Price by Type (2025-2030) & (USD/Dose)
Table 45. Global Pneumococcal Vaccine Revenue by End User 2019 VS 2023 VS 2030 (US$ Million)
Table 46. Global Pneumococcal Vaccine Revenue by End User (2019-2024) & (US$ Million)
Table 47. Global Pneumococcal Vaccine Revenue by End User (2025-2030) & (US$ Million)
Table 48. Global Pneumococcal Vaccine Revenue Market Share by End User (2019-2024)
Table 49. Global Pneumococcal Vaccine Revenue Market Share by End User (2025-2030)
Table 50. Global Pneumococcal Vaccine Sales by End User 2019 VS 2023 VS 2030 (K Doses)
Table 51. Global Pneumococcal Vaccine Sales by End User (2019-2024) & (K Doses)
Table 52. Global Pneumococcal Vaccine Sales by End User (2025-2030) & (K Doses)
Table 53. Global Pneumococcal Vaccine Sales Market Share by End User (2019-2024)
Table 54. Global Pneumococcal Vaccine Sales Market Share by End User (2025-2030)
Table 55. Global Pneumococcal Vaccine Price by End User (2019-2024) & (USD/Dose)
Table 56. Global Pneumococcal Vaccine Price by End User (2025-2030) & (USD/Dose)
Table 57. Pfizer Company Information
Table 58. Pfizer Business Overview
Table 59. Pfizer Pneumococcal Vaccine Sales (K Doses), Revenue (US$ Million), Price (USD/Dose) and Gross Margin (2019-2024)
Table 60. Pfizer Pneumococcal Vaccine Product Portfolio
Table 61. Pfizer Recent Development
Table 62. GSK Company Information
Table 63. GSK Business Overview
Table 64. GSK Pneumococcal Vaccine Sales (K Doses), Revenue (US$ Million), Price (USD/Dose) and Gross Margin (2019-2024)
Table 65. GSK Pneumococcal Vaccine Product Portfolio
Table 66. GSK Recent Development
Table 67. MSD Company Information
Table 68. MSD Business Overview
Table 69. MSD Pneumococcal Vaccine Sales (K Doses), Revenue (US$ Million), Price (USD/Dose) and Gross Margin (2019-2024)
Table 70. MSD Pneumococcal Vaccine Product Portfolio
Table 71. MSD Recent Development
Table 72. Sanofipasteur Company Information
Table 73. Sanofipasteur Business Overview
Table 74. Sanofipasteur Pneumococcal Vaccine Sales (K Doses), Revenue (US$ Million), Price (USD/Dose) and Gross Margin (2019-2024)
Table 75. Sanofipasteur Pneumococcal Vaccine Product Portfolio
Table 76. Sanofipasteur Recent Development
Table 77. CDIBP Company Information
Table 78. CDIBP Business Overview
Table 79. CDIBP Pneumococcal Vaccine Sales (K Doses), Revenue (US$ Million), Price (USD/Dose) and Gross Margin (2019-2024)
Table 80. CDIBP Pneumococcal Vaccine Product Portfolio
Table 81. CDIBP Recent Development
Table 82. North America Pneumococcal Vaccine Revenue by Type (2019-2024) & (US$ Million)
Table 83. North America Pneumococcal Vaccine Revenue by Type (2025-2030) & (US$ Million)
Table 84. North America Pneumococcal Vaccine Sales by Type (2019-2024) & (K Doses)
Table 85. North America Pneumococcal Vaccine Sales by Type (2025-2030) & (K Doses)
Table 86. North America Pneumococcal Vaccine Sales Price by Type (2019-2024) & (USD/Dose)
Table 87. North America Pneumococcal Vaccine Sales Price by Type (2025-2030) & (USD/Dose)
Table 88. North America Pneumococcal Vaccine Revenue by End User (2019-2024) & (US$ Million)
Table 89. North America Pneumococcal Vaccine Revenue by End User (2025-2030) & (US$ Million)
Table 90. North America Pneumococcal Vaccine Sales by End User (2019-2024) & (K Doses)
Table 91. North America Pneumococcal Vaccine Sales by End User (2025-2030) & (K Doses)
Table 92. North America Pneumococcal Vaccine Sales Price by End User (2019-2024) & (USD/Dose)
Table 93. North America Pneumococcal Vaccine Sales Price by End User (2025-2030) & (USD/Dose)
Table 94. North America Pneumococcal Vaccine Revenue Grow Rate by Country (2019 VS 2023 VS 2030) & (US$ Million)
Table 95. North America Pneumococcal Vaccine Revenue Grow Rate by Country (2019-2024) & (US$ Million)
Table 96. North America Pneumococcal Vaccine Revenue Grow Rate by Country (2025-2030) & (US$ Million)
Table 97. North America Pneumococcal Vaccine Sales by Country (2019 VS 2023 VS 2030) & (K Doses)
Table 98. North America Pneumococcal Vaccine Sales by Country (2019-2024) & (K Doses)
Table 99. North America Pneumococcal Vaccine Sales by Country (2025-2030) & (K Doses)
Table 100. North America Pneumococcal Vaccine Sales Price by Country (2019-2024) & (USD/Dose)
Table 101. North America Pneumococcal Vaccine Sales Price by Country (2025-2030) & (USD/Dose)
Table 102. US Pneumococcal Vaccine Revenue (2019-2030) & (US$ Million)
Table 103. Canada Pneumococcal Vaccine Revenue (2019-2030) & (US$ Million)
Table 104. Europe Pneumococcal Vaccine Revenue by Type (2019-2024) & (US$ Million)
Table 105. Europe Pneumococcal Vaccine Revenue by Type (2025-2030) & (US$ Million)
Table 106. Europe Pneumococcal Vaccine Sales by Type (2019-2024) & (K Doses)
Table 107. Europe Pneumococcal Vaccine Sales by Type (2025-2030) & (K Doses)
Table 108. Europe Pneumococcal Vaccine Sales Price by Type (2019-2024) & (USD/Dose)
Table 109. Europe Pneumococcal Vaccine Sales Price by Type (2025-2030) & (USD/Dose)
Table 110. Europe Pneumococcal Vaccine Revenue by End User (2019-2024) & (US$ Million)
Table 111. Europe Pneumococcal Vaccine Revenue by End User (2025-2030) & (US$ Million)
Table 112. Europe Pneumococcal Vaccine Sales by End User (2019-2024) & (K Doses)
Table 113. Europe Pneumococcal Vaccine Sales by End User (2025-2030) & (K Doses)
Table 114. Europe Pneumococcal Vaccine Sales Price by End User (2019-2024) & (USD/Dose)
Table 115. Europe Pneumococcal Vaccine Sales Price by End User (2025-2030) & (USD/Dose)
Table 116. Europe Pneumococcal Vaccine Revenue Grow Rate by Country (2019 VS 2023 VS 2030) & (US$ Million)
Table 117. Europe Pneumococcal Vaccine Revenue Grow Rate by Country (2019-2024) & (US$ Million)
Table 118. Europe Pneumococcal Vaccine Revenue Grow Rate by Country (2025-2030) & (US$ Million)
Table 119. Europe Pneumococcal Vaccine Sales by Country (2019 VS 2023 VS 2030) & (K Doses)
Table 120. Europe Pneumococcal Vaccine Sales by Country (2019-2024) & (K Doses)
Table 121. Europe Pneumococcal Vaccine Sales by Country (2025-2030) & (K Doses)
Table 122. Europe Pneumococcal Vaccine Sales Price by Country (2019-2024) & (USD/Dose)
Table 123. Europe Pneumococcal Vaccine Sales Price by Country (2025-2030) & (USD/Dose)
Table 124. Germany Pneumococcal Vaccine Revenue (2019-2030) & (US$ Million)
Table 125. France Pneumococcal Vaccine Revenue (2019-2030) & (US$ Million)
Table 126. Pneumococcal Vaccine Revenue (2019-2030) & (US$ Million)
Table 127. Pneumococcal Vaccine Revenue (2019-2030) & (US$ Million)
Table 128. Pneumococcal Vaccine Revenue (2019-2030) & (US$ Million)
Table 129. China Pneumococcal Vaccine Revenue by Type (2019-2024) & (US$ Million)
Table 130. China Pneumococcal Vaccine Revenue by Type (2025-2030) & (US$ Million)
Table 131. China Pneumococcal Vaccine Sales by Type (2019-2024) & (K Doses)
Table 132. China Pneumococcal Vaccine Sales by Type (2025-2030) & (K Doses)
Table 133. China Pneumococcal Vaccine Sales Price by Type (2019-2024) & (USD/Dose)
Table 134. China Pneumococcal Vaccine Sales Price by Type (2025-2030) & (USD/Dose)
Table 135. China Pneumococcal Vaccine Revenue by End User (2019-2024) & (US$ Million)
Table 136. China Pneumococcal Vaccine Revenue by End User (2025-2030) & (US$ Million)
Table 137. China Pneumococcal Vaccine Sales by End User (2019-2024) & (K Doses)
Table 138. China Pneumococcal Vaccine Sales by End User (2025-2030) & (K Doses)
Table 139. China Pneumococcal Vaccine Sales Price by End User (2019-2024) & (USD/Dose)
Table 140. China Pneumococcal Vaccine Sales Price by End User (2025-2030) & (USD/Dose)
Table 141. Asia Pneumococcal Vaccine Revenue by Type (2019-2024) & (US$ Million)
Table 142. Asia Pneumococcal Vaccine Revenue by Type (2025-2030) & (US$ Million)
Table 143. Asia Pneumococcal Vaccine Sales by Type (2019-2024) & (K Doses)
Table 144. Asia Pneumococcal Vaccine Sales by Type (2025-2030) & (K Doses)
Table 145. Asia Pneumococcal Vaccine Sales Price by Type (2019-2024) & (USD/Dose)
Table 146. Asia Pneumococcal Vaccine Sales Price by Type (2025-2030) & (USD/Dose)
Table 147. Asia Pneumococcal Vaccine Revenue by End User (2019-2024) & (US$ Million)
Table 148. Asia Pneumococcal Vaccine Revenue by End User (2025-2030) & (US$ Million)
Table 149. Asia Pneumococcal Vaccine Sales by End User (2019-2024) & (K Doses)
Table 150. Asia Pneumococcal Vaccine Sales by End User (2025-2030) & (K Doses)
Table 151. Asia Pneumococcal Vaccine Sales Price by End User (2019-2024) & (USD/Dose)
Table 152. Asia Pneumococcal Vaccine Sales Price by End User (2025-2030) & (USD/Dose)
Table 153. Asia Pneumococcal Vaccine Revenue Grow Rate by Country (2019 VS 2023 VS 2030) & (US$ Million)
Table 154. Asia Pneumococcal Vaccine Revenue Grow Rate by Country (2019-2024) & (US$ Million)
Table 155. Asia Pneumococcal Vaccine Revenue Grow Rate by Country (2025-2030) & (US$ Million)
Table 156. Asia Pneumococcal Vaccine Sales by Country (2019 VS 2023 VS 2030) & (K Doses)
Table 157. Asia Pneumococcal Vaccine Sales by Country (2019-2024) & (K Doses)
Table 158. Asia Pneumococcal Vaccine Sales by Country (2025-2030) & (K Doses)
Table 159. Asia Pneumococcal Vaccine Sales Price by Country (2019-2024) & (USD/Dose)
Table 160. Asia Pneumococcal Vaccine Sales Price by Country (2025-2030) & (USD/Dose)
Table 161. Japan Pneumococcal Vaccine Revenue (2019-2030) & (US$ Million)
Table 162. South Korea Pneumococcal Vaccine Revenue (2019-2030) & (US$ Million)
Table 163. Pneumococcal Vaccine Revenue (2019-2030) & (US$ Million)
Table 164. Pneumococcal Vaccine Revenue (2019-2030) & (US$ Million)
Table 165. Pneumococcal Vaccine Revenue (2019-2030) & (US$ Million)
Table 166. Pneumococcal Vaccine Revenue (2019-2030) & (US$ Million)
Table 167. Pneumococcal Vaccine Revenue (2019-2030) & (US$ Million)
Table 168. Pneumococcal Vaccine Revenue (2019-2030) & (US$ Million)
Table 169. MEALA Pneumococcal Vaccine Revenue by Type (2019-2024) & (US$ Million)
Table 170. MEALA Pneumococcal Vaccine Revenue by Type (2025-2030) & (US$ Million)
Table 171. MEALA Pneumococcal Vaccine Sales by Type (2019-2024) & (K Doses)
Table 172. MEALA Pneumococcal Vaccine Sales by Type (2025-2030) & (K Doses)
Table 173. MEALA Pneumococcal Vaccine Sales Price by Type (2019-2024) & (USD/Dose)
Table 174. MEALA Pneumococcal Vaccine Sales Price by Type (2025-2030) & (USD/Dose)
Table 175. MEALA Pneumococcal Vaccine Revenue by End User (2019-2024) & (US$ Million)
Table 176. MEALA Pneumococcal Vaccine Revenue by End User (2025-2030) & (US$ Million)
Table 177. MEALA Pneumococcal Vaccine Sales by End User (2019-2024) & (K Doses)
Table 178. MEALA Pneumococcal Vaccine Sales by End User (2025-2030) & (K Doses)
Table 179. MEALA Pneumococcal Vaccine Sales Price by End User (2019-2024) & (USD/Dose)
Table 180. MEALA Pneumococcal Vaccine Sales Price by End User (2025-2030) & (USD/Dose)
Table 181. MEALA Pneumococcal Vaccine Revenue Grow Rate by Country (2019 VS 2023 VS 2030) & (US$ Million)
Table 182. MEALA Pneumococcal Vaccine Revenue Grow Rate by Country (2019-2024) & (US$ Million)
Table 183. MEALA Pneumococcal Vaccine Revenue Grow Rate by Country (2025-2030) & (US$ Million)
Table 184. MEALA Pneumococcal Vaccine Sales by Country (2019 VS 2023 VS 2030) & (K Doses)
Table 185. MEALA Pneumococcal Vaccine Sales by Country (2019-2024) & (K Doses)
Table 186. MEALA Pneumococcal Vaccine Sales by Country (2025-2030) & (K Doses)
Table 187. MEALA Pneumococcal Vaccine Sales Price by Country (2019-2024) & (USD/Dose)
Table 188. MEALA Pneumococcal Vaccine Sales Price by Country (2025-2030) & (USD/Dose)
Table 189. Mexico Pneumococcal Vaccine Revenue (2019-2030) & (US$ Million)
Table 190. Brazil Pneumococcal Vaccine Revenue (2019-2030) & (US$ Million)
Table 191. Israel Pneumococcal Vaccine Revenue (2019-2030) & (US$ Million)
Table 192. Argentina Pneumococcal Vaccine Revenue (2019-2030) & (US$ Million)
Table 193. Colombia Pneumococcal Vaccine Revenue (2019-2030) & (US$ Million)
Table 194. Turkey Pneumococcal Vaccine Revenue (2019-2030) & (US$ Million)
Table 195. Saudi Arabia Pneumococcal Vaccine Revenue (2019-2030) & (US$ Million)
Table 196. UAE Pneumococcal Vaccine Revenue (2019-2030) & (US$ Million)
Table 197. Key Raw Materials
Table 198. Raw Materials Key Suppliers
Table 199. Pneumococcal Vaccine Distributors List
Table 200. Pneumococcal Vaccine Customers List
Table 201. Research Programs/Design for This Report
Table 202. Authors List of This Report
Table 203. Secondary Sources
Table 204. Primary Sources
Table 1. Global Pneumococcal Vaccine Market Size Growth Rate by Type (US$ Million), 2019 VS 2023 VS 2030
Table 2. PPSV 23 Major Manufacturers
Table 3. PCV 7/13 Major Manufacturers
Table 4. PCV 10 Major Manufacturers
Table 5. Global Pneumococcal Vaccine Market Size Growth Rate by End User (US$ Million), 2019 VS 2023 VS 2030
Table 6. Child Major Manufacturers
Table 7. Adult Major Manufacturers
Table 8. Pneumococcal Vaccine Industry Trends
Table 9. Pneumococcal Vaccine Industry Drivers
Table 10. Pneumococcal Vaccine Industry Opportunities and Challenges
Table 11. Pneumococcal Vaccine Industry Restraints
Table 12. Global Pneumococcal Vaccine Revenue Grow Rate (CAGR) by Region: 2019 VS 2023 VS 2030 (US$ Million)
Table 13. Global Pneumococcal Vaccine Revenue by Region (2019-2024) & (US$ Million)
Table 14. Global Pneumococcal Vaccine Revenue by Region (2025-2030) & (US$ Million)
Table 15. Global Pneumococcal Vaccine Revenue Market Share by Region (2019-2024)
Table 16. Global Pneumococcal Vaccine Revenue Market Share by Region (2025-2030)
Table 17. Global Pneumococcal Vaccine Sales Grow Rate (CAGR) by Region: 2019 VS 2023 VS 2030 (K Doses)
Table 18. Global Pneumococcal Vaccine Sales by Region (2019-2024) & (K Doses)
Table 19. Global Pneumococcal Vaccine Sales by Region (2025-2030) & (K Doses)
Table 20. Global Pneumococcal Vaccine Sales Market Share by Region (2019-2024)
Table 21. Global Pneumococcal Vaccine Sales Market Share by Region (2025-2030)
Table 22. Global Pneumococcal Vaccine Revenue by Manufacturers (US$ Million) & (2019-2024)
Table 23. Global Pneumococcal Vaccine Revenue Market Share by Manufacturers (2019-2024)
Table 24. Global Pneumococcal Vaccine Sales by Manufacturers (US$ Million) & (2019-2024)
Table 25. Global Pneumococcal Vaccine Sales Market Share by Manufacturers (2019-2024)
Table 26. Global Pneumococcal Vaccine Sales Price (USD/Dose) of Manufacturers (2019-2024)
Table 27. Global Pneumococcal Vaccine Key Manufacturers Ranking, 2022 VS 2023 VS 2024
Table 28. Global Pneumococcal Vaccine Key Manufacturers Manufacturing Sites & Headquarters
Table 29. Global Pneumococcal Vaccine Manufacturers, Product Type & Application
Table 30. Global Pneumococcal Vaccine Manufacturers Commercialization Time
Table 31. Global Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 32. Global Pneumococcal Vaccine by Manufacturers Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue of 2023)
Table 33. Global Pneumococcal Vaccine Revenue by Type 2019 VS 2023 VS 2030 (US$ Million)
Table 34. Global Pneumococcal Vaccine Revenue by Type (2019-2024) & (US$ Million)
Table 35. Global Pneumococcal Vaccine Revenue by Type (2025-2030) & (US$ Million)
Table 36. Global Pneumococcal Vaccine Revenue Market Share by Type (2019-2024)
Table 37. Global Pneumococcal Vaccine Revenue Market Share by Type (2025-2030)
Table 38. Global Pneumococcal Vaccine Sales by Type 2019 VS 2023 VS 2030 (K Doses)
Table 39. Global Pneumococcal Vaccine Sales by Type (2019-2024) & (K Doses)
Table 40. Global Pneumococcal Vaccine Sales by Type (2025-2030) & (K Doses)
Table 41. Global Pneumococcal Vaccine Sales Market Share by Type (2019-2024)
Table 42. Global Pneumococcal Vaccine Sales Market Share by Type (2025-2030)
Table 43. Global Pneumococcal Vaccine Price by Type (2019-2024) & (USD/Dose)
Table 44. Global Pneumococcal Vaccine Price by Type (2025-2030) & (USD/Dose)
Table 45. Global Pneumococcal Vaccine Revenue by End User 2019 VS 2023 VS 2030 (US$ Million)
Table 46. Global Pneumococcal Vaccine Revenue by End User (2019-2024) & (US$ Million)
Table 47. Global Pneumococcal Vaccine Revenue by End User (2025-2030) & (US$ Million)
Table 48. Global Pneumococcal Vaccine Revenue Market Share by End User (2019-2024)
Table 49. Global Pneumococcal Vaccine Revenue Market Share by End User (2025-2030)
Table 50. Global Pneumococcal Vaccine Sales by End User 2019 VS 2023 VS 2030 (K Doses)
Table 51. Global Pneumococcal Vaccine Sales by End User (2019-2024) & (K Doses)
Table 52. Global Pneumococcal Vaccine Sales by End User (2025-2030) & (K Doses)
Table 53. Global Pneumococcal Vaccine Sales Market Share by End User (2019-2024)
Table 54. Global Pneumococcal Vaccine Sales Market Share by End User (2025-2030)
Table 55. Global Pneumococcal Vaccine Price by End User (2019-2024) & (USD/Dose)
Table 56. Global Pneumococcal Vaccine Price by End User (2025-2030) & (USD/Dose)
Table 57. Pfizer Company Information
Table 58. Pfizer Business Overview
Table 59. Pfizer Pneumococcal Vaccine Sales (K Doses), Revenue (US$ Million), Price (USD/Dose) and Gross Margin (2019-2024)
Table 60. Pfizer Pneumococcal Vaccine Product Portfolio
Table 61. Pfizer Recent Development
Table 62. GSK Company Information
Table 63. GSK Business Overview
Table 64. GSK Pneumococcal Vaccine Sales (K Doses), Revenue (US$ Million), Price (USD/Dose) and Gross Margin (2019-2024)
Table 65. GSK Pneumococcal Vaccine Product Portfolio
Table 66. GSK Recent Development
Table 67. MSD Company Information
Table 68. MSD Business Overview
Table 69. MSD Pneumococcal Vaccine Sales (K Doses), Revenue (US$ Million), Price (USD/Dose) and Gross Margin (2019-2024)
Table 70. MSD Pneumococcal Vaccine Product Portfolio
Table 71. MSD Recent Development
Table 72. Sanofipasteur Company Information
Table 73. Sanofipasteur Business Overview
Table 74. Sanofipasteur Pneumococcal Vaccine Sales (K Doses), Revenue (US$ Million), Price (USD/Dose) and Gross Margin (2019-2024)
Table 75. Sanofipasteur Pneumococcal Vaccine Product Portfolio
Table 76. Sanofipasteur Recent Development
Table 77. CDIBP Company Information
Table 78. CDIBP Business Overview
Table 79. CDIBP Pneumococcal Vaccine Sales (K Doses), Revenue (US$ Million), Price (USD/Dose) and Gross Margin (2019-2024)
Table 80. CDIBP Pneumococcal Vaccine Product Portfolio
Table 81. CDIBP Recent Development
Table 82. North America Pneumococcal Vaccine Revenue by Type (2019-2024) & (US$ Million)
Table 83. North America Pneumococcal Vaccine Revenue by Type (2025-2030) & (US$ Million)
Table 84. North America Pneumococcal Vaccine Sales by Type (2019-2024) & (K Doses)
Table 85. North America Pneumococcal Vaccine Sales by Type (2025-2030) & (K Doses)
Table 86. North America Pneumococcal Vaccine Sales Price by Type (2019-2024) & (USD/Dose)
Table 87. North America Pneumococcal Vaccine Sales Price by Type (2025-2030) & (USD/Dose)
Table 88. North America Pneumococcal Vaccine Revenue by End User (2019-2024) & (US$ Million)
Table 89. North America Pneumococcal Vaccine Revenue by End User (2025-2030) & (US$ Million)
Table 90. North America Pneumococcal Vaccine Sales by End User (2019-2024) & (K Doses)
Table 91. North America Pneumococcal Vaccine Sales by End User (2025-2030) & (K Doses)
Table 92. North America Pneumococcal Vaccine Sales Price by End User (2019-2024) & (USD/Dose)
Table 93. North America Pneumococcal Vaccine Sales Price by End User (2025-2030) & (USD/Dose)
Table 94. North America Pneumococcal Vaccine Revenue Grow Rate by Country (2019 VS 2023 VS 2030) & (US$ Million)
Table 95. North America Pneumococcal Vaccine Revenue Grow Rate by Country (2019-2024) & (US$ Million)
Table 96. North America Pneumococcal Vaccine Revenue Grow Rate by Country (2025-2030) & (US$ Million)
Table 97. North America Pneumococcal Vaccine Sales by Country (2019 VS 2023 VS 2030) & (K Doses)
Table 98. North America Pneumococcal Vaccine Sales by Country (2019-2024) & (K Doses)
Table 99. North America Pneumococcal Vaccine Sales by Country (2025-2030) & (K Doses)
Table 100. North America Pneumococcal Vaccine Sales Price by Country (2019-2024) & (USD/Dose)
Table 101. North America Pneumococcal Vaccine Sales Price by Country (2025-2030) & (USD/Dose)
Table 102. US Pneumococcal Vaccine Revenue (2019-2030) & (US$ Million)
Table 103. Canada Pneumococcal Vaccine Revenue (2019-2030) & (US$ Million)
Table 104. Europe Pneumococcal Vaccine Revenue by Type (2019-2024) & (US$ Million)
Table 105. Europe Pneumococcal Vaccine Revenue by Type (2025-2030) & (US$ Million)
Table 106. Europe Pneumococcal Vaccine Sales by Type (2019-2024) & (K Doses)
Table 107. Europe Pneumococcal Vaccine Sales by Type (2025-2030) & (K Doses)
Table 108. Europe Pneumococcal Vaccine Sales Price by Type (2019-2024) & (USD/Dose)
Table 109. Europe Pneumococcal Vaccine Sales Price by Type (2025-2030) & (USD/Dose)
Table 110. Europe Pneumococcal Vaccine Revenue by End User (2019-2024) & (US$ Million)
Table 111. Europe Pneumococcal Vaccine Revenue by End User (2025-2030) & (US$ Million)
Table 112. Europe Pneumococcal Vaccine Sales by End User (2019-2024) & (K Doses)
Table 113. Europe Pneumococcal Vaccine Sales by End User (2025-2030) & (K Doses)
Table 114. Europe Pneumococcal Vaccine Sales Price by End User (2019-2024) & (USD/Dose)
Table 115. Europe Pneumococcal Vaccine Sales Price by End User (2025-2030) & (USD/Dose)
Table 116. Europe Pneumococcal Vaccine Revenue Grow Rate by Country (2019 VS 2023 VS 2030) & (US$ Million)
Table 117. Europe Pneumococcal Vaccine Revenue Grow Rate by Country (2019-2024) & (US$ Million)
Table 118. Europe Pneumococcal Vaccine Revenue Grow Rate by Country (2025-2030) & (US$ Million)
Table 119. Europe Pneumococcal Vaccine Sales by Country (2019 VS 2023 VS 2030) & (K Doses)
Table 120. Europe Pneumococcal Vaccine Sales by Country (2019-2024) & (K Doses)
Table 121. Europe Pneumococcal Vaccine Sales by Country (2025-2030) & (K Doses)
Table 122. Europe Pneumococcal Vaccine Sales Price by Country (2019-2024) & (USD/Dose)
Table 123. Europe Pneumococcal Vaccine Sales Price by Country (2025-2030) & (USD/Dose)
Table 124. Germany Pneumococcal Vaccine Revenue (2019-2030) & (US$ Million)
Table 125. France Pneumococcal Vaccine Revenue (2019-2030) & (US$ Million)
Table 126. Pneumococcal Vaccine Revenue (2019-2030) & (US$ Million)
Table 127. Pneumococcal Vaccine Revenue (2019-2030) & (US$ Million)
Table 128. Pneumococcal Vaccine Revenue (2019-2030) & (US$ Million)
Table 129. China Pneumococcal Vaccine Revenue by Type (2019-2024) & (US$ Million)
Table 130. China Pneumococcal Vaccine Revenue by Type (2025-2030) & (US$ Million)
Table 131. China Pneumococcal Vaccine Sales by Type (2019-2024) & (K Doses)
Table 132. China Pneumococcal Vaccine Sales by Type (2025-2030) & (K Doses)
Table 133. China Pneumococcal Vaccine Sales Price by Type (2019-2024) & (USD/Dose)
Table 134. China Pneumococcal Vaccine Sales Price by Type (2025-2030) & (USD/Dose)
Table 135. China Pneumococcal Vaccine Revenue by End User (2019-2024) & (US$ Million)
Table 136. China Pneumococcal Vaccine Revenue by End User (2025-2030) & (US$ Million)
Table 137. China Pneumococcal Vaccine Sales by End User (2019-2024) & (K Doses)
Table 138. China Pneumococcal Vaccine Sales by End User (2025-2030) & (K Doses)
Table 139. China Pneumococcal Vaccine Sales Price by End User (2019-2024) & (USD/Dose)
Table 140. China Pneumococcal Vaccine Sales Price by End User (2025-2030) & (USD/Dose)
Table 141. Asia Pneumococcal Vaccine Revenue by Type (2019-2024) & (US$ Million)
Table 142. Asia Pneumococcal Vaccine Revenue by Type (2025-2030) & (US$ Million)
Table 143. Asia Pneumococcal Vaccine Sales by Type (2019-2024) & (K Doses)
Table 144. Asia Pneumococcal Vaccine Sales by Type (2025-2030) & (K Doses)
Table 145. Asia Pneumococcal Vaccine Sales Price by Type (2019-2024) & (USD/Dose)
Table 146. Asia Pneumococcal Vaccine Sales Price by Type (2025-2030) & (USD/Dose)
Table 147. Asia Pneumococcal Vaccine Revenue by End User (2019-2024) & (US$ Million)
Table 148. Asia Pneumococcal Vaccine Revenue by End User (2025-2030) & (US$ Million)
Table 149. Asia Pneumococcal Vaccine Sales by End User (2019-2024) & (K Doses)
Table 150. Asia Pneumococcal Vaccine Sales by End User (2025-2030) & (K Doses)
Table 151. Asia Pneumococcal Vaccine Sales Price by End User (2019-2024) & (USD/Dose)
Table 152. Asia Pneumococcal Vaccine Sales Price by End User (2025-2030) & (USD/Dose)
Table 153. Asia Pneumococcal Vaccine Revenue Grow Rate by Country (2019 VS 2023 VS 2030) & (US$ Million)
Table 154. Asia Pneumococcal Vaccine Revenue Grow Rate by Country (2019-2024) & (US$ Million)
Table 155. Asia Pneumococcal Vaccine Revenue Grow Rate by Country (2025-2030) & (US$ Million)
Table 156. Asia Pneumococcal Vaccine Sales by Country (2019 VS 2023 VS 2030) & (K Doses)
Table 157. Asia Pneumococcal Vaccine Sales by Country (2019-2024) & (K Doses)
Table 158. Asia Pneumococcal Vaccine Sales by Country (2025-2030) & (K Doses)
Table 159. Asia Pneumococcal Vaccine Sales Price by Country (2019-2024) & (USD/Dose)
Table 160. Asia Pneumococcal Vaccine Sales Price by Country (2025-2030) & (USD/Dose)
Table 161. Japan Pneumococcal Vaccine Revenue (2019-2030) & (US$ Million)
Table 162. South Korea Pneumococcal Vaccine Revenue (2019-2030) & (US$ Million)
Table 163. Pneumococcal Vaccine Revenue (2019-2030) & (US$ Million)
Table 164. Pneumococcal Vaccine Revenue (2019-2030) & (US$ Million)
Table 165. Pneumococcal Vaccine Revenue (2019-2030) & (US$ Million)
Table 166. Pneumococcal Vaccine Revenue (2019-2030) & (US$ Million)
Table 167. Pneumococcal Vaccine Revenue (2019-2030) & (US$ Million)
Table 168. Pneumococcal Vaccine Revenue (2019-2030) & (US$ Million)
Table 169. MEALA Pneumococcal Vaccine Revenue by Type (2019-2024) & (US$ Million)
Table 170. MEALA Pneumococcal Vaccine Revenue by Type (2025-2030) & (US$ Million)
Table 171. MEALA Pneumococcal Vaccine Sales by Type (2019-2024) & (K Doses)
Table 172. MEALA Pneumococcal Vaccine Sales by Type (2025-2030) & (K Doses)
Table 173. MEALA Pneumococcal Vaccine Sales Price by Type (2019-2024) & (USD/Dose)
Table 174. MEALA Pneumococcal Vaccine Sales Price by Type (2025-2030) & (USD/Dose)
Table 175. MEALA Pneumococcal Vaccine Revenue by End User (2019-2024) & (US$ Million)
Table 176. MEALA Pneumococcal Vaccine Revenue by End User (2025-2030) & (US$ Million)
Table 177. MEALA Pneumococcal Vaccine Sales by End User (2019-2024) & (K Doses)
Table 178. MEALA Pneumococcal Vaccine Sales by End User (2025-2030) & (K Doses)
Table 179. MEALA Pneumococcal Vaccine Sales Price by End User (2019-2024) & (USD/Dose)
Table 180. MEALA Pneumococcal Vaccine Sales Price by End User (2025-2030) & (USD/Dose)
Table 181. MEALA Pneumococcal Vaccine Revenue Grow Rate by Country (2019 VS 2023 VS 2030) & (US$ Million)
Table 182. MEALA Pneumococcal Vaccine Revenue Grow Rate by Country (2019-2024) & (US$ Million)
Table 183. MEALA Pneumococcal Vaccine Revenue Grow Rate by Country (2025-2030) & (US$ Million)
Table 184. MEALA Pneumococcal Vaccine Sales by Country (2019 VS 2023 VS 2030) & (K Doses)
Table 185. MEALA Pneumococcal Vaccine Sales by Country (2019-2024) & (K Doses)
Table 186. MEALA Pneumococcal Vaccine Sales by Country (2025-2030) & (K Doses)
Table 187. MEALA Pneumococcal Vaccine Sales Price by Country (2019-2024) & (USD/Dose)
Table 188. MEALA Pneumococcal Vaccine Sales Price by Country (2025-2030) & (USD/Dose)
Table 189. Mexico Pneumococcal Vaccine Revenue (2019-2030) & (US$ Million)
Table 190. Brazil Pneumococcal Vaccine Revenue (2019-2030) & (US$ Million)
Table 191. Israel Pneumococcal Vaccine Revenue (2019-2030) & (US$ Million)
Table 192. Argentina Pneumococcal Vaccine Revenue (2019-2030) & (US$ Million)
Table 193. Colombia Pneumococcal Vaccine Revenue (2019-2030) & (US$ Million)
Table 194. Turkey Pneumococcal Vaccine Revenue (2019-2030) & (US$ Million)
Table 195. Saudi Arabia Pneumococcal Vaccine Revenue (2019-2030) & (US$ Million)
Table 196. UAE Pneumococcal Vaccine Revenue (2019-2030) & (US$ Million)
Table 197. Key Raw Materials
Table 198. Raw Materials Key Suppliers
Table 199. Pneumococcal Vaccine Distributors List
Table 200. Pneumococcal Vaccine Customers List
Table 201. Research Programs/Design for This Report
Table 202. Authors List of This Report
Table 203. Secondary Sources
Table 204. Primary Sources
LIST OF FIGURES
Figure 1. Pneumococcal Vaccine Product Picture
Figure 2. Global Pneumococcal Vaccine Market Size Growth Rate by Type (US$ Million), 2019 VS 2023 VS 2030
Figure 3. Global Pneumococcal Vaccine Market Size Share 2019 VS 2023 VS 2030
Figure 4. PPSV 23 Picture
Figure 5. PCV 7/13 Picture
Figure 6. PCV 10 Picture
Figure 7. Global Pneumococcal Vaccine Market Size Growth Rate by End User (US$ Million), 2019 VS 2023 VS 2030
Figure 8. Global Pneumococcal Vaccine Market Size Share 2019 VS 2023 VS 2030
Figure 9. Child Picture
Figure 10. Adult Picture
Figure 11. Global Pneumococcal Vaccine Revenue (US$ Million), 2019 VS 2023 VS 2030
Figure 12. Global Pneumococcal Vaccine Revenue (2019-2030) & (US$ Million)
Figure 13. Global Pneumococcal Vaccine Revenue (CAGR) by Region: 2019 VS 2023 VS 2030 (US$ Million)
Figure 14. Global Pneumococcal Vaccine Revenue Market Share by Region: 2023 Versus 2030
Figure 15. Global Pneumococcal Vaccine Revenue Market Share by Region (2019-2030)
Figure 16. Global Pneumococcal Vaccine Sales (2019-2030) & (K Doses)
Figure 17. Global Pneumococcal Vaccine Sales (CAGR) by Region: 2019 VS 2023 VS 2030 (K Doses)
Figure 18. Global Pneumococcal Vaccine Sales Market Share by Region (2019-2030)
Figure 19. US & Canada Pneumococcal Vaccine Sales YoY (2019-2030) & (K Doses)
Figure 20. Europe Pneumococcal Vaccine Sales YoY (2019-2030) & (K Doses)
Figure 21. China Pneumococcal Vaccine Sales YoY (2019-2030) & (K Doses)
Figure 22. Asia (Excluding China) Pneumococcal Vaccine Sales YoY (2019-2030) & (K Doses)
Figure 23. Middle East, Africa and Latin America (Excluding China) Pneumococcal Vaccine Sales YoY (2019-2030) & (K Doses)
Figure 24. Global Pneumococcal Vaccine Manufacturers Revenue Share Top 10 and Top 5 in 2023
Figure 25. Global Pneumococcal Vaccine Manufacturers Sales Share Top 10 and Top 5 in 2023
Figure 26. Manufacturers Type (Tier 1, Tier 2, and Tier 3): 2019 VS 2023
Figure 27. Global Pneumococcal Vaccine Revenue by Type (2019 VS 2023 VS 2030) & (US$ Million)
Figure 28. Global Pneumococcal Vaccine Revenue Market Share by Type 2019 VS 2023 VS 2030
Figure 29. Global Pneumococcal Vaccine Revenue Market Share by Type (2019-2030)
Figure 30. Global Pneumococcal Vaccine Sales by Type (2019 VS 2023 VS 2030) & (K Doses)
Figure 31. Global Pneumococcal Vaccine Sales Market Share by Type 2019 VS 2023 VS 2030
Figure 32. Global Pneumococcal Vaccine Sales Market Share by Type (2019-2030)
Figure 33. Global Pneumococcal Vaccine Revenue by End User (2019 VS 2023 VS 2030) & (US$ Million)
Figure 34. Global Pneumococcal Vaccine Revenue Market Share by Application 2019 VS 2023 VS 2030
Figure 35. Global Pneumococcal Vaccine Revenue Market Share by End User (2019-2030)
Figure 36. Global Pneumococcal Vaccine Sales by End User (2019 VS 2023 VS 2030) & (K Doses)
Figure 37. Global Pneumococcal Vaccine Sales Market Share by Application 2019 VS 2023 VS 2030
Figure 38. Global Pneumococcal Vaccine Sales Market Share by End User (2019-2030)
Figure 39. North America Pneumococcal Vaccine Revenue Share by Type (2019-2030)
Figure 40. North America Pneumococcal Vaccine Sales Share by Type (2019-2030)
Figure 41. North America Pneumococcal Vaccine Revenue Share by End User (2019-2030)
Figure 42. North America Pneumococcal Vaccine Sales Share by End User (2019-2030)
Figure 43. North America Pneumococcal Vaccine Revenue Share by Country (2019-2030)
Figure 44. North America Pneumococcal Vaccine Sales Share by Country (2019-2030)
Figure 45. Europe Pneumococcal Vaccine Revenue Share by Type (2019-2030)
Figure 46. Europe Pneumococcal Vaccine Sales Share by Type (2019-2030)
Figure 47. Europe Pneumococcal Vaccine Revenue Share by End User (2019-2030)
Figure 48. Europe Pneumococcal Vaccine Sales Share by End User (2019-2030)
Figure 49. Europe Pneumococcal Vaccine Revenue Share by Country (2019-2030)
Figure 50. Europe Pneumococcal Vaccine Sales Share by Country (2019-2030)
Figure 51. China Pneumococcal Vaccine Revenue Share by Type (2019-2030)
Figure 52. China Pneumococcal Vaccine Sales Share by Type (2019-2030)
Figure 53. China Pneumococcal Vaccine Revenue Share by End User (2019-2030)
Figure 54. China Pneumococcal Vaccine Sales Share by End User (2019-2030)
Figure 55. Asia Pneumococcal Vaccine Revenue Share by Type (2019-2030)
Figure 56. Asia Pneumococcal Vaccine Sales Share by Type (2019-2030)
Figure 57. Asia Pneumococcal Vaccine Revenue Share by End User (2019-2030)
Figure 58. Asia Pneumococcal Vaccine Sales Share by End User (2019-2030)
Figure 59. Asia Pneumococcal Vaccine Revenue Shar
Figure 1. Pneumococcal Vaccine Product Picture
Figure 2. Global Pneumococcal Vaccine Market Size Growth Rate by Type (US$ Million), 2019 VS 2023 VS 2030
Figure 3. Global Pneumococcal Vaccine Market Size Share 2019 VS 2023 VS 2030
Figure 4. PPSV 23 Picture
Figure 5. PCV 7/13 Picture
Figure 6. PCV 10 Picture
Figure 7. Global Pneumococcal Vaccine Market Size Growth Rate by End User (US$ Million), 2019 VS 2023 VS 2030
Figure 8. Global Pneumococcal Vaccine Market Size Share 2019 VS 2023 VS 2030
Figure 9. Child Picture
Figure 10. Adult Picture
Figure 11. Global Pneumococcal Vaccine Revenue (US$ Million), 2019 VS 2023 VS 2030
Figure 12. Global Pneumococcal Vaccine Revenue (2019-2030) & (US$ Million)
Figure 13. Global Pneumococcal Vaccine Revenue (CAGR) by Region: 2019 VS 2023 VS 2030 (US$ Million)
Figure 14. Global Pneumococcal Vaccine Revenue Market Share by Region: 2023 Versus 2030
Figure 15. Global Pneumococcal Vaccine Revenue Market Share by Region (2019-2030)
Figure 16. Global Pneumococcal Vaccine Sales (2019-2030) & (K Doses)
Figure 17. Global Pneumococcal Vaccine Sales (CAGR) by Region: 2019 VS 2023 VS 2030 (K Doses)
Figure 18. Global Pneumococcal Vaccine Sales Market Share by Region (2019-2030)
Figure 19. US & Canada Pneumococcal Vaccine Sales YoY (2019-2030) & (K Doses)
Figure 20. Europe Pneumococcal Vaccine Sales YoY (2019-2030) & (K Doses)
Figure 21. China Pneumococcal Vaccine Sales YoY (2019-2030) & (K Doses)
Figure 22. Asia (Excluding China) Pneumococcal Vaccine Sales YoY (2019-2030) & (K Doses)
Figure 23. Middle East, Africa and Latin America (Excluding China) Pneumococcal Vaccine Sales YoY (2019-2030) & (K Doses)
Figure 24. Global Pneumococcal Vaccine Manufacturers Revenue Share Top 10 and Top 5 in 2023
Figure 25. Global Pneumococcal Vaccine Manufacturers Sales Share Top 10 and Top 5 in 2023
Figure 26. Manufacturers Type (Tier 1, Tier 2, and Tier 3): 2019 VS 2023
Figure 27. Global Pneumococcal Vaccine Revenue by Type (2019 VS 2023 VS 2030) & (US$ Million)
Figure 28. Global Pneumococcal Vaccine Revenue Market Share by Type 2019 VS 2023 VS 2030
Figure 29. Global Pneumococcal Vaccine Revenue Market Share by Type (2019-2030)
Figure 30. Global Pneumococcal Vaccine Sales by Type (2019 VS 2023 VS 2030) & (K Doses)
Figure 31. Global Pneumococcal Vaccine Sales Market Share by Type 2019 VS 2023 VS 2030
Figure 32. Global Pneumococcal Vaccine Sales Market Share by Type (2019-2030)
Figure 33. Global Pneumococcal Vaccine Revenue by End User (2019 VS 2023 VS 2030) & (US$ Million)
Figure 34. Global Pneumococcal Vaccine Revenue Market Share by Application 2019 VS 2023 VS 2030
Figure 35. Global Pneumococcal Vaccine Revenue Market Share by End User (2019-2030)
Figure 36. Global Pneumococcal Vaccine Sales by End User (2019 VS 2023 VS 2030) & (K Doses)
Figure 37. Global Pneumococcal Vaccine Sales Market Share by Application 2019 VS 2023 VS 2030
Figure 38. Global Pneumococcal Vaccine Sales Market Share by End User (2019-2030)
Figure 39. North America Pneumococcal Vaccine Revenue Share by Type (2019-2030)
Figure 40. North America Pneumococcal Vaccine Sales Share by Type (2019-2030)
Figure 41. North America Pneumococcal Vaccine Revenue Share by End User (2019-2030)
Figure 42. North America Pneumococcal Vaccine Sales Share by End User (2019-2030)
Figure 43. North America Pneumococcal Vaccine Revenue Share by Country (2019-2030)
Figure 44. North America Pneumococcal Vaccine Sales Share by Country (2019-2030)
Figure 45. Europe Pneumococcal Vaccine Revenue Share by Type (2019-2030)
Figure 46. Europe Pneumococcal Vaccine Sales Share by Type (2019-2030)
Figure 47. Europe Pneumococcal Vaccine Revenue Share by End User (2019-2030)
Figure 48. Europe Pneumococcal Vaccine Sales Share by End User (2019-2030)
Figure 49. Europe Pneumococcal Vaccine Revenue Share by Country (2019-2030)
Figure 50. Europe Pneumococcal Vaccine Sales Share by Country (2019-2030)
Figure 51. China Pneumococcal Vaccine Revenue Share by Type (2019-2030)
Figure 52. China Pneumococcal Vaccine Sales Share by Type (2019-2030)
Figure 53. China Pneumococcal Vaccine Revenue Share by End User (2019-2030)
Figure 54. China Pneumococcal Vaccine Sales Share by End User (2019-2030)
Figure 55. Asia Pneumococcal Vaccine Revenue Share by Type (2019-2030)
Figure 56. Asia Pneumococcal Vaccine Sales Share by Type (2019-2030)
Figure 57. Asia Pneumococcal Vaccine Revenue Share by End User (2019-2030)
Figure 58. Asia Pneumococcal Vaccine Sales Share by End User (2019-2030)
Figure 59. Asia Pneumococcal Vaccine Revenue Shar
